Evidence map›Paper›PMID 36613822›Full record

ReviewInternational journal of molecular sciences2022

Effects of Oleuropein and Hydroxytyrosol on Inflammatory Mediators: Consequences on Inflammaging.

Fanny Pojero, Anna Aiello, Francesco Gervasi, Calogero Caruso, Mattia Emanuela Ligotti, Anna Calabrò, Antonio Procopio, Giuseppina Candore, Giulia Accardi, Mario Allegra

Open access · goldAbstract readReview
In one paragraph

Review in International journal of molecular sciences, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 31 papers.

0numbers the graph read from it
0cells of the map it votes in
31citing papers in PubMed
4.6field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

31 citing papers in PubMed, 45 citations in OpenAlex.

  1. Trial
  2. Article
  3. Review
  4. Review
  5. Review
  6. Article
  7. Review
  8. Article
  9. Review
  10. Article
  11. Article
  12. Review
  13. Article
  14. Review
  15. Article
  16. Review
  17. Review
  18. Article
  19. Review
  20. The Role of Natural Products in Immunopharmacology.International journal of molecular sciences · 2024
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 3 institutions in 1 country.

Fanny PojeroLaboratory of Immunopathology and Immunosenescence, Department of Biomedicine, Neurosciences and Advanced Technologies, University of Palermo, 90134 Palermo, Italy.ORCID 0000-0002-4971-240X
Anna AielloLaboratory of Immunopathology and Immunosenescence, Department of Biomedicine, Neurosciences and Advanced Technologies, University of Palermo, 90134 Palermo, Italy.ORCID 0000-0003-2593-3221
Francesco GervasiSpecialistic Oncology Laboratory Unit, ARNAS Hospitals Civico Di Cristina e Benfratelli, 90127 Palermo, Italy.ORCID 0000-0002-9052-7206
Calogero CarusoLaboratory of Immunopathology and Immunosenescence, Department of Biomedicine, Neurosciences and Advanced Technologies, University of Palermo, 90134 Palermo, Italy.ORCID 0000-0001-8004-2363
Mattia Emanuela LigottiLaboratory of Immunopathology and Immunosenescence, Department of Biomedicine, Neurosciences and Advanced Technologies, University of Palermo, 90134 Palermo, Italy.
Anna CalabròLaboratory of Immunopathology and Immunosenescence, Department of Biomedicine, Neurosciences and Advanced Technologies, University of Palermo, 90134 Palermo, Italy.
Antonio ProcopioDepartment of Health Sciences, University Magna Graecia of Catanzaro, 88100 Catanzaro, Italy.
Giuseppina CandoreLaboratory of Immunopathology and Immunosenescence, Department of Biomedicine, Neurosciences and Advanced Technologies, University of Palermo, 90134 Palermo, Italy.ORCID 0000-0002-9966-934X
Giulia AccardiLaboratory of Immunopathology and Immunosenescence, Department of Biomedicine, Neurosciences and Advanced Technologies, University of Palermo, 90134 Palermo, Italy.ORCID 0000-0003-3565-9529
Mario AllegraDepartment of Biological, Chemical and Pharmaceutical Sciences and Technologies, University of Palermo, 90123 Palermo, Italy.ORCID 0000-0002-5846-1868
University of Palermo · ITAzienda di Rilievo Nazionale ed Alta Specializzazione · ITMagna Graecia University · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Aging is associated with a low-grade, systemic inflammatory state defined as "inflammaging", ruled by the loss of proper regulation of the immune system leading to the accumulation of pro-inflammatory mediators. Such a condition is closely connected to an increased risk of developing chronic diseases. A number of studies demonstrate that olive oil phenolic compound oleuropein and its derivative hydroxytyrosol contribute to modulating tissue inflammation and oxidative stress, thus becoming attractive potential candidates to be used in the context of nutraceutical interventions, in order to ameliorate systemic inflammation in aging subjects. In this review, we aim to summarize the available data about the anti-inflammatory properties of oleuropein and hydroxytyrosol, discussing them in the light of molecular pathways involved in the synthesis and release of inflammatory mediators in inflammaging.

Indexed as

Inflammation MediatorsPhenylethyl AlcoholAntioxidantsHumansInflammationIridoid GlucosidesIridoidsOlive Oil3,4-dihydroxyphenylethanolAntioxidantsInflammation MediatorsIridoid GlucosidesIridoidsoleuropeinOlive OilPhenylethyl Alcoholhydroxytyrosolinflammagingnutraceuticaloleuropein

Identifiers

PMID36613822
PMCPMC9820525
OpenAlexW4312201936

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.